Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-26 @ 8:27 PM
Study NCT ID:
NCT00660959
Status:
COMPLETED
Last Update Posted:
2011-06-28
First Post:
2008-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D007010', 'term': 'Hyponatremia'}, {'id': 'D004487', 'term': 'Edema'}], 'ancestors': [{'id': 'D014883', 'term': 'Water-Electrolyte Imbalance'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C409452', 'term': 'lixivaptan'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 106}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2008-04'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2010-11', 'dispFirstSubmitDate': '2011-06-20', 'lastUpdateSubmitDate': '2011-06-20', 'studyFirstSubmitDate': '2008-04-15', 'dispFirstSubmitQcDate': '2011-06-20', 'studyFirstSubmitQcDate': '2008-04-17', 'dispFirstPostDateStruct': {'date': '2011-06-28', 'type': 'ESTIMATED'}, 'lastUpdatePostDateStruct': {'date': '2011-06-28', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2008-04-18', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2010-06', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Average daily area under the curve (AUC) of change from baseline in serum sodium concentrations up to 72 hrs in lixivaptan treated subjects compared to placebo', 'timeFrame': '60 days'}], 'secondaryOutcomes': [{'measure': 'Change from baseline in serum sodium on Day 30', 'timeFrame': '60 days'}, {'measure': 'Percentage of subjects achieving normalized serum sodium (Na+ ≥ 135 mEq/L)', 'timeFrame': '60 days'}, {'measure': 'Time to first normalization of serum sodium (Na+≥135 mEq/L)', 'timeFrame': '60 days'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['Euvolemic', 'Hyponatremia', 'Serum Sodium', 'Fluid Overload', 'Vasopressin Antagonist'], 'conditions': ['Hyponatremia With Normal Extracellular Fluid Volume']}, 'descriptionModule': {'briefSummary': 'The present study is designed to confirm and extend the observation from previous studies that lixivaptan therapy corrects hyponatremia, in euvolemic subject, including subjects with SIADH.', 'detailedDescription': 'Phase I Phase II clinical trials have demonstrated that lixivaptan may play an important role in treating hyponatremia and the signs and symptoms of water retention associated with HF, liver cirrhosis with ascites (LCWA) and syndrome of inappropriate antidiuretic hormone (SIADH). Lixivaptan was previously evaluated in disease states characterized by hyponatremia with euvolemia (SIADH)and hyponatremia combined with fluid overload (HF, LCWA). Lixivaptan resulted in correction in hyponatremia together with a marked aquaresis in subject with volume overload. The present study is designed to confirm and extend the observation from previous studies that lixivaptan therapy corrects hyponatremia, in euvolemic subject, including subjects with SIDH.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Written informed consent\n* Men or women aged 18 or older\n* Diagnosis of euvolemic hyponatremia (120 ≤ Na+\\<130 mEq/L)\n* Hospitalized or willing to be admitted to a monitored setting for approximately the first 48 hours of treatment\n\nExclusion Criteria:\n\n* Pregnant or breast-feeding women, or women planning to become pregnant or to breastfeed\n* Symptomatic hyponatremia (e.g., lethargy, coma, seizures, changes in mental status attributable to hyponatremia)\n* Acute or transient hyponatremia (e.g., associated with head trauma or postoperative state)\n* Hyponatremia in hypovolemic states. Hypovolemic hyponatremia is defined as the presence of clinical evidence of extracellular fluid volume depletion\n* Hyponatremia as a result of any medication that can safely be withdrawn\n* Hyponatremia due to hypothyroidism or adrenal insufficiency\n* Diagnosis of psychogenic polydipsia\n* Receiving within 7 days of enrollment, other medication for treatment of hyponatremia specifically: demeclocycline, lithium carbonate, urea, or conivaptan\n* Use of radiotherapy and chemotherapy within 2 wks of randomization\n* Likely to require, or to receive IV saline for correction of symptomatic or asymptomatic severe hyponatremia during the course of the study\n* Supine systolic arterial blood pressure of ≤ 90 mmHg\n* Serum creatinine \\>3.0 mg/dL\n* History of uncontrolled type 2 diabetes mellitus\n* Severe pulmonary artery hypertension: patients whose condition is expected to deteriorate with sudden shifts in fluid volumes and cardiac filling pressures\n* Established diagnosis of New York Heart Association (NYHA) class III or IV heart failure\n* History of myocardial infarction, unstable angina or evidence of active ischemia within 30 days prior to screening\n* History of cerebral vascular accident (CVA) within 60 days prior to screening\n* Established diagnosis of nephrotic syndrome\n* Advanced liver disease or documented diagnosis of cirrhosis or alcoholic hepatitis\n* Urinary tract obstruction (benign prostatic hypertrophy \\[BPH\\] allowed if non-obstructive)\n* History of alcohol abuse or illicit drug use within the past 6 months\n* Terminally ill or moribund condition with little chance of short-term survival\n* Receiving vasopressin or its analogs for treatment of any condition\n* Known allergy to any vasopressin antagonist\n* Previous participation in a lixivaptan study\n* Recipient of any investigational treatment (drug or device) within 30 days prior to baseline visit\n* Unable to take oral medications'}, 'identificationModule': {'nctId': 'NCT00660959', 'briefTitle': 'Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia', 'organization': {'class': 'INDUSTRY', 'fullName': 'CardioKine Inc.'}, 'officialTitle': 'Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia', 'orgStudyIdInfo': {'id': 'CK-LX3405'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Active Comparator', 'description': 'lixivaptan', 'interventionNames': ['Drug: lixivaptan']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'placebo', 'interventionNames': ['Drug: placebo']}], 'interventions': [{'name': 'lixivaptan', 'type': 'DRUG', 'description': 'oral capsule', 'armGroupLabels': ['Active Comparator']}, {'name': 'placebo', 'type': 'DRUG', 'description': 'oral capsule', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '36617', 'city': 'Mobile', 'state': 'Alabama', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 30.69436, 'lon': -88.04305}}, {'zip': '85050', 'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'PsyPharma Global', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '90033', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '90073', 'city': 'Los Angeles', 'state': 'California', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '95661', 'city': 'Roseville', 'state': 'California', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 38.75212, 'lon': -121.28801}}, {'zip': '80045', 'city': 'Aurora', 'state': 'Colorado', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 39.72943, 'lon': -104.83192}}, {'zip': '20037', 'city': 'Washington D.C.', 'state': 'District of Columbia', 'country': 'United States', 'facility': 'The George Washington University Medical Faculty Associates', 'geoPoint': {'lat': 38.89511, 'lon': -77.03637}}, {'zip': '33161', 'city': 'North Miami', 'state': 'Florida', 'country': 'United States', 'facility': 'Healthcare Clinical Data, Inc', 'geoPoint': {'lat': 25.89009, 'lon': -80.18671}}, {'zip': '33331', 'city': 'Weston', 'state': 'Florida', 'country': 'United States', 'facility': 'Cleveland Clinic Florida', 'geoPoint': {'lat': 26.10037, 'lon': -80.39977}}, {'zip': '30912', 'city': 'Augusta', 'state': 'Georgia', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 33.47097, 'lon': -81.97484}}, {'zip': '31419', 'city': 'Savannah', 'state': 'Georgia', 'country': 'United States', 'facility': 'RTR Medical Group', 'geoPoint': {'lat': 32.08354, 'lon': -81.09983}}, {'zip': '60612', 'city': 'Chicago', 'state': 'Illinois', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '52242', 'city': 'Iowa City', 'state': 'Iowa', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 41.66113, 'lon': -91.53017}}, {'zip': '42003', 'city': 'Paducah', 'state': 'Kentucky', 'country': 'United States', 'facility': 'Four Rivers Clinical Research, Inc.', 'geoPoint': {'lat': 37.08339, 'lon': -88.60005}}, {'zip': '70114', 'city': 'New Orleans', 'state': 'Louisiana', 'country': 'United States', 'facility': 'Louisiana Research Associates, Inc.', 'geoPoint': {'lat': 29.95465, 'lon': -90.07507}}, {'zip': '02478', 'city': 'Belmont', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 42.39593, 'lon': -71.17867}}, {'zip': '02135', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02212', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Beth Israel Deaconess Medical Center', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '64128', 'city': 'Kansas City', 'state': 'Missouri', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 39.09973, 'lon': -94.57857}}, {'zip': '89106', 'city': 'Las Vegas', 'state': 'Nevada', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '12208', 'city': 'Albany', 'state': 'New York', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 42.65258, 'lon': -73.75623}}, {'zip': '14215', 'city': 'Buffalo', 'state': 'New York', 'country': 'United States', 'facility': 'Erie County Medical Center', 'geoPoint': {'lat': 42.88645, 'lon': -78.87837}}, {'zip': '10016', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '27983', 'city': 'Windsor', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Three Rivers Health and Rehabilitation', 'geoPoint': {'lat': 35.99849, 'lon': -76.94606}}, {'zip': '45005', 'city': 'Middletown', 'state': 'Ohio', 'country': 'United States', 'facility': 'Atrium Medical Center', 'geoPoint': {'lat': 39.51506, 'lon': -84.39828}}, {'zip': '43609', 'city': 'Toledo', 'state': 'Ohio', 'country': 'United States', 'facility': 'Kettlie Joseph Daniels MD, Inc', 'geoPoint': {'lat': 41.66394, 'lon': -83.55521}}, {'zip': '17011', 'city': 'Camp Hill', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 40.23981, 'lon': -76.91997}}, {'zip': '18901', 'city': 'Doylestown', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 40.31011, 'lon': -75.12989}}, {'zip': '19401', 'city': 'Norristown', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 40.1215, 'lon': -75.3399}}, {'zip': '19104', 'city': 'Philadelphia', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 39.95238, 'lon': -75.16362}}, {'zip': '02903', 'city': 'Providence', 'state': 'Rhode Island', 'country': 'United States', 'facility': 'Research Site', 'geoPoint': {'lat': 41.82399, 'lon': -71.41283}}, {'zip': '29209', 'city': 'Columbia', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Research Site 1', 'geoPoint': {'lat': 34.00071, 'lon': -81.03481}}, {'zip': '78626', 'city': 'Georgetown', 'state': 'Texas', 'country': 'United States', 'facility': 'SunStar Geriatrics Healthcare', 'geoPoint': {'lat': 30.63269, 'lon': -97.67723}}, {'zip': '77074', 'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'Clinical Trial Network', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'zip': '84058', 'city': 'Orem', 'state': 'Utah', 'country': 'United States', 'facility': 'Aspen Clinical Research', 'geoPoint': {'lat': 40.2969, 'lon': -111.69465}}, {'zip': '23507', 'city': 'Norfolk', 'state': 'Virginia', 'country': 'United States', 'facility': 'The Glennan Center for Geriatrics and Gerontology', 'geoPoint': {'lat': 36.84681, 'lon': -76.28522}}, {'zip': '98405', 'city': 'Tacoma', 'state': 'Washington', 'country': 'United States', 'facility': 'Internal Medicine Northwest', 'geoPoint': {'lat': 47.25288, 'lon': -122.44429}}, {'zip': '3000', 'city': 'Leuven', 'country': 'Belgium', 'facility': 'UZ Gasthulsberg', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': '1480', 'city': 'Tubize', 'country': 'Belgium', 'facility': 'Centre Hospitalier de Tubize', 'geoPoint': {'lat': 50.69059, 'lon': 4.2009}}, {'zip': 'J4V 2H1', 'city': 'Greenfield Park', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Research SIte', 'geoPoint': {'lat': 45.48649, 'lon': -73.46223}}, {'zip': 'H1T 2M4', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Research Site 1', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'H4J 1C5', 'city': 'Montreal', 'state': 'Quebec', 'country': 'Canada', 'facility': 'Research Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': '01307', 'city': 'Dresden', 'state': 'Germany', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 51.05089, 'lon': 13.73832}}, {'zip': '30167', 'city': 'Hanover', 'state': 'Hannover', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 52.37052, 'lon': 9.73322}}, {'zip': '39120', 'city': 'Magdeburg', 'state': 'Magdeburg', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 52.13129, 'lon': 11.63189}}, {'zip': '12200', 'city': 'Berlin', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '13353', 'city': 'Berlin', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '35392', 'city': 'Giessen', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 50.58727, 'lon': 8.67554}}, {'zip': '69120', 'city': 'Heidelberg', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 49.40768, 'lon': 8.69079}}, {'zip': '78464', 'city': 'Konstanz', 'country': 'Germany', 'facility': 'Research SIte', 'geoPoint': {'lat': 47.66033, 'lon': 9.17582}}, {'zip': '80336', 'city': 'München', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '97080', 'city': 'Würzburg', 'country': 'Germany', 'facility': 'Research Site', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'zip': '673004', 'city': 'Calicut', 'state': 'Kerala', 'country': 'India', 'facility': 'Baby Memorial Hospital', 'geoPoint': {'lat': 11.24802, 'lon': 75.7804}}, {'zip': '411 030', 'city': 'Pune', 'state': 'Maharashtra', 'country': 'India', 'facility': 'Poona Hospital and Research Centre', 'geoPoint': {'lat': 18.51957, 'lon': 73.85535}}, {'zip': '110 065', 'city': 'New Delhi', 'state': 'New Delhi', 'country': 'India', 'facility': 'Vidya Sagar Institute of Mental Health and Neurosciences', 'geoPoint': {'lat': 28.62137, 'lon': 77.2148}}, {'zip': '110060', 'city': 'Old Rajinder Nagar', 'state': 'New Delhi', 'country': 'India', 'facility': 'Sir Ganga Ram Hospital'}, {'zip': '411 004', 'city': 'Erandawane', 'state': 'Pune', 'country': 'India', 'facility': 'Deenanath Mengeshkar Hospital & Research Centre'}, {'zip': '302017', 'city': 'Jaipur', 'state': 'Rajasthan', 'country': 'India', 'facility': 'Fortis Escorts Hospital', 'geoPoint': {'lat': 26.91962, 'lon': 75.78781}}, {'zip': '08-300', 'city': 'Podlaski', 'state': 'Poland', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 53.09312, 'lon': 17.80653}}, {'city': 'Warsaw', 'state': 'Poland', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '22-400', 'city': 'Zamość', 'state': 'Zamosc', 'country': 'Poland', 'facility': 'Samodzielny Publiczny Szpital Wojewodzki im. Papieza Jana Pawla II', 'geoPoint': {'lat': 50.72314, 'lon': 23.25196}}, {'zip': '85-094', 'city': 'Bydgoszcz', 'country': 'Poland', 'facility': 'Research Site', 'geoPoint': {'lat': 53.1235, 'lon': 18.00762}}, {'zip': '06400', 'city': 'Ciechanów', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 52.88141, 'lon': 20.61996}}, {'zip': '40-027', 'city': 'Katowice', 'country': 'Poland', 'facility': 'Research Site', 'geoPoint': {'lat': 50.2597, 'lon': 19.02173}}, {'zip': '90-153', 'city': 'Lodz', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 51.77058, 'lon': 19.47395}}, {'zip': '20-954', 'city': 'Lublin', 'country': 'Poland', 'facility': 'Research Site', 'geoPoint': {'lat': 51.25058, 'lon': 22.57009}}, {'zip': '02-097', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '02-097', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'Research Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '02-507', 'city': 'Warsaw', 'country': 'Poland', 'facility': 'Research Site 1', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '90-302', 'city': 'Wilgury', 'state': 'Łódź Voivodeship', 'country': 'Poland', 'facility': 'Niepubliczny Zaklad Opieki Zdrowotney'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'CardioKine Inc.', 'class': 'INDUSTRY'}, 'collaborators': [{'name': 'Cardiokine Biopharma, LLC', 'class': 'INDUSTRY'}, {'name': 'Biogen', 'class': 'INDUSTRY'}], 'responsibleParty': {'oldNameTitle': 'Cardiokine, Inc', 'oldOrganization': 'Cardiokine, Inc'}}}}